Eve Health Group Limited has released a press release.
Oversubscribed Placement & Rights Issue to Raise up to $6.3m
Filed with ASX ·
6ix hasn’t read this filing yet.
EVE Health Group Limited on 6ix
Story so far
Earlier from EVE Health
- Eagle Begins Shipment of Omni Innovations Diabetes Product
- Meluka Health to Develop Honey Water for Chinese Market
- Eve Completes 50% Investment in Meluka Health
- Response to ASX Price & Volume Query
- NSW Grant for Honey Research Successful
Later from EVE Health
- Meluka Consumer Products Launch at US Natural Products Expo
- Half Yearly Report and Accounts
- First Quarter China Sales Progress
- EVE to Acquire Leading Aust Organic Tea Tree Oil Producer
- Update on THC Agreements
Follow EVE Health into a list and get an email when it puts out news.
Follow EVE Health